Related references
Note: Only part of the references are listed.The Prodrug Platin-A: Simultaneous Release of Cisplatin and Aspirin
Rakesh K. Pathak et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
Copper-Free Click-Chemistry Platform to Functionalize Cisplatin Prodrugs
Rakesh K. Pathak et al.
CHEMISTRY-A EUROPEAN JOURNAL (2014)
Ex Vivo Programming of Dendritic Cells by Mitochondria-Targeted Nanoparticles to Produce Interferon-Gamma for Cancer Immunotherapy
Sean Marrache et al.
ACS NANO (2013)
Targeting Mitochondrial DNA with a Platinum-Based Anticancer Agent
Simon P. Wisnovsky et al.
CHEMISTRY & BIOLOGY (2013)
Mitochondrially targeted compounds and their impact on cellular bioenergetics
Colin Reily et al.
REDOX BIOLOGY (2013)
Engineering of blended nanoparticle platform for delivery of mitochondria-acting therapeutics
Sean Marrache et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy
Nagesh Kolishetti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
CNS Delivery Via Adsorptive Transcytosis
Francoise Herve et al.
AAPS JOURNAL (2008)
A novel role for mitochondria in regulating epigenetic modification in the nucleus
Dominic J. Smiraglia et al.
CANCER BIOLOGY & THERAPY (2008)
Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles
Shanta Dhar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Nanocarriers as an emerging platform for cancer therapy
Dan Peer et al.
NATURE NANOTECHNOLOGY (2007)
Cisplatin preferentially binds mitochondrial DNA and voltage-dependent anion channel protein in the mitochondrial membrane of head and neck squamous cell carcinoma: Possible role in apoptosis
Zejia Yang et al.
CLINICAL CANCER RESEARCH (2006)